- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03737747
Synek Score to Predict Poor Neurological Outcome Post Resuscitated Cardiac Arrest
The Performance of the Synek Score to Predict Poor Neurological Outcome in Postanoxic Comatose Patients Treated With Induced Hypothermia
Resuscitated cardiac arrest (CA) is a frequent cause of admission in intensive care unit (ICU). Neurological state of postanoxic comatose patients can evolve either towards the absence of awakening or towards a more or less altered state of consciousness, ranging from the vegetative state to the full recovery of cognitive functions. Most of the deaths result from active withdrawal of life-sustaining treatment, based on poor neurological outcome prediction. Neurological prognostication needs therefore a multimodal approach based on reliable parameters, which should be easy to access and available at the early stage of care, in attempt to limit false poor outcome prognostication and help to not prolong futile active care in patient with severe post anoxic cerebral lesions. Nowadays the prediction of neurological outcome relies on a multimodal strategy including clinical examination, biomarkers and electroencephalography (Guidelines ESICM 2015). Early standard electroencephalography (EEG) is currently recommended and some features, notably absence of reactivity, status epilepticus or burst suppression after rewarming are strongly predictive of poor outcome. But those features require a precise analyze of the EEG usually performed by specialist. EEG patterns can be simplified and classified in five grades according to the Synek classification, ranging from dominant reactive alpha activity (grade 1) to isoelectric encephalogram (grade 5). Grade 1 and two are considering as good prognostic, grade 3 as intermediate and grade 4 to five as poor prognostic. Nevertheless, few data are available on the performance of this classification since generalization of TTM use.
We hypothesize that a multimodal strategy combining clinical examination, NSE concentration and the Synek score would bring a high degree of prediction. We aimed to assess the performances of the combination of clinical examination, NSE analysed at 48-72h and the Synek score to predict hard outcome defined by a cerebral performance category (CPC) 3-5, in postanoxic comatose patients treated with induced hypothermia
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Amiens, France, 80000
- CHU Amiens Picardie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Age ≥ 18 years with inclusion criteria : Will be considered for inclusion patients admitted in our ICU following a resuscitate cardiac arrest between November 1, 2013 to November 1, 2017 , treated with 33° induced hypothermia for 24 h, having at least one early EEG rated according to Synek score and an available dosage of NSE performed within 48-72h post CA.
exclusion criteria: moribund patients, awoke within the first 48 hours of admission, neurologic causes of CA, and patients with missing data
Description
Inclusion Criteria:
- patients admitted in our ICU following a resuscitate cardiac arrest between November 1, 2013 to November 1, 2017
- treated with 33° induced hypothermia for 24 h
- having at least one early EEG rated according to Synek score
- available dosage of NSE performed within 48-72h post CA
Exclusion Criteria:
- moribund patients
- awoke within the first 48 hours of admission
- neurologic causes of CA
- patients with missing data
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary outcome is the CPC 3-5 score at 3 months or at death time
Time Frame: at 3 months
|
at 3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2018_843_0045
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on induced hypothermia
-
Australia and New Zealand Intensive Care SocietyCompletedTraumatic Brain InjuryAustralia, New Zealand
-
Phoenix Children's HospitalNational Institutes of Health (NIH)TerminatedTraumatic Brain InjuryUnited States, Australia, Canada, New Zealand, South Africa, United Kingdom
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedHypoxia-Ischemia, Brain | Infant, NewbornUnited States
-
Danish Procalcitonin Study GroupLundbeck Foundation; TRYG FoundationTerminatedSeptic ShockNetherlands, Denmark, United States
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaUnknownPulseless Electrical Activity | Asystole | Postcardiac ArrestCanada
-
Imperial College LondonMedical Research CouncilCompletedHypoxia | Seizures | Asphyxia Neonatorum | EncephalopathyUnited Kingdom
-
Thomas Jefferson UniversityUnknownHypothermia | Cerebral HemorrhageUnited States
-
Mid and South Essex NHS Foundation TrustCompletedCardiac ArrestUnited Kingdom
-
University of California, San FranciscoTerminated
-
Assistance Publique - Hôpitaux de ParisTerminated